Plasma Protein Therapeutics Association (PPTA)/LinkedIn
Oct 4, 2025, 12:25
The Patient Experience In The US: Access To Plasma-Derived Medicines – PPTA Webinar
Plasma Protein Therapeutics Association (PPTA) posted on LinkedIn:
”Join PPTA for a candid conversation with patients who use plasma-derived medicines to treat their rare diseases. They’ll explain the challenges, successes, and hopes for the future of plasma- derived medicines during a free webinar moderated by PPTA President and CEO Anita Brikman.
Monday, Oct. 6 at 2 pm ET/ 11 am PT
Virtual webinar – free to attend
Secure your spot today.”
Keep up with Hemostasis Today.
-
Dec 16, 2025, 16:34Mads Krogsgaard Thomsen on Novo Nordisk Haemophilia Foundation’s Support for Haemoglobinopathies
-
Dec 16, 2025, 16:22Leonardo Furtado Freitas Presents a Rare Hemorrhagic Hemangioblastoma Case
-
Dec 16, 2025, 16:14Nicolas Gendron on Sustainability in Anticoagulation and DOACs
-
Dec 16, 2025, 15:39Reza Shojaei: Every Expired Unit of Blood Tells a Story
-
Dec 16, 2025, 14:03Francesco Lo Monaco on Rethinking Blood Pressure: The Major Problem with How We Understand It
-
Dec 16, 2025, 14:03Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
-
Dec 16, 2025, 14:02Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms
-
Dec 16, 2025, 13:58AHA Awards Shubham Misra Postdoc Grant for LVO Stroke Biomarker Research
-
Dec 16, 2025, 13:00ScholarGPS Ranks Emmanuel J. Favaloro No. 1 in the World for Hemostasis